[
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID101",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 2.9,
    "Overall Survival (Months)": 4.8,
    "MSK ID": "NR8727"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID102",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "LS",
    "Response Group": "Non-Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 49.7,
    "Overall Survival (Months)": 50,
    "MSK ID": "LSDNR9298"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID103",
    "Primary Tumor/Cancer Type": "Acral Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 5.1,
    "Overall Survival (Months)": 18,
    "MSK ID": "NR1867"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID104",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "SD",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 3.1,
    "Overall Survival (Months)": 19.2,
    "MSK ID": "SD5934"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID105",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Non-Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 86.1,
    "Overall Survival (Months)": 86.4,
    "MSK ID": "CRNR4941"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID106",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "LS",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 87.7,
    "Overall Survival (Months)": 87.6,
    "MSK ID": "LSD4691"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID107",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 2.5,
    "Overall Survival (Months)": 20.4,
    "MSK ID": "NR4045"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID108",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Non-Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 25,
    "Overall Survival (Months)": 25.2,
    "MSK ID": "CRNR0244"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID109",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 10.6,
    "Overall Survival (Months)": 32.4,
    "MSK ID": "CR3665"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID110",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "PR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 72.3,
    "Overall Survival (Months)": 72.7,
    "MSK ID": "PR4077"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID111",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 2.7,
    "Overall Survival (Months)": 32.4,
    "MSK ID": "NR9521"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID112",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "SD",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 15,
    "Overall Survival (Months)": 34.8,
    "MSK ID": "SD0346"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID113",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 15.8,
    "Overall Survival (Months)": 54,
    "MSK ID": "CR1509"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID114",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 5.1,
    "Overall Survival (Months)": 8.4,
    "MSK ID": "NR4949"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID115",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "SD",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 5.3,
    "Overall Survival (Months)": 14.4,
    "MSK ID": "SD5038"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID116",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 49.5,
    "Overall Survival (Months)": 51.2,
    "MSK ID": "CR22640"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID117",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 2.4,
    "Overall Survival (Months)": 6,
    "MSK ID": "NR5784"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID118",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 11.4,
    "Overall Survival (Months)": 52.8,
    "MSK ID": "CR9699"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID119",
    "Primary Tumor/Cancer Type": "Acral Melanoma",
    "Response": "SD",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 5.3,
    "Overall Survival (Months)": 32.4,
    "MSK ID": "SD5118"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID120",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "PR",
    "Response Group": "Non-Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 54,
    "Overall Survival (Months)": 94.6,
    "MSK ID": "PR03803"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID121",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 19.5,
    "Overall Survival (Months)": 25.6,
    "MSK ID": "CR04885"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID122",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 2.4,
    "Overall Survival (Months)": 3.3,
    "MSK ID": "NR4018"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID123",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 2.4,
    "Overall Survival (Months)": 13.2,
    "MSK ID": "NR3156"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID124",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "PR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 49.9,
    "Overall Survival (Months)": 50.2,
    "MSK ID": "PR4035"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID125",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 9.2,
    "Overall Survival (Months)": 63.6,
    "MSK ID": "CR9306"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID126",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "SD",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 4.6,
    "Overall Survival (Months)": 24,
    "MSK ID": "SD7357"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID127",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 14.3,
    "Overall Survival (Months)": 68.4,
    "MSK ID": "CR0095"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID128",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "SD",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 45.8,
    "Overall Survival (Months)": 46.8,
    "MSK ID": "SD2056"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID129",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 0.7,
    "Overall Survival (Months)": 9.6,
    "MSK ID": "NR6721"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID130",
    "Primary Tumor/Cancer Type": "Acral Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 6.6,
    "Overall Survival (Months)": 14.4,
    "MSK ID": "NR9705"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID131",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 2.6,
    "Overall Survival (Months)": 4.8,
    "MSK ID": "NR4810"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID132",
    "Primary Tumor/Cancer Type": "Acral Melanoma",
    "Response": "SD",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 3.5,
    "Overall Survival (Months)": 9.6,
    "MSK ID": "SD2051"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID133",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "LS",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 18.3,
    "Overall Survival (Months)": 25.2,
    "MSK ID": "LSD4744"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID134",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "LS",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 32.1,
    "Overall Survival (Months)": 32.4,
    "MSK ID": "LSD0167"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID135",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 31.2,
    "Overall Survival (Months)": 31.3,
    "MSK ID": "CR6161"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID136",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 3.5,
    "Overall Survival (Months)": 6,
    "MSK ID": "NR3549"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID137",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 23.1,
    "Overall Survival (Months)": 22.8,
    "MSK ID": "CR6126"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID138",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "LS",
    "Response Group": "Non-Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 30.9,
    "Overall Survival (Months)": 31.2,
    "MSK ID": "LSDNR3086"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID139",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 38.5,
    "Overall Survival (Months)": 44.4,
    "MSK ID": "CR06670"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID140",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 3,
    "Overall Survival (Months)": 6,
    "MSK ID": "NR4631"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID141",
    "Primary Tumor/Cancer Type": "NA",
    "Response": "SD",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 79.4,
    "Overall Survival (Months)": 82.8,
    "MSK ID": "SD6336"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID142",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "LS",
    "Response Group": "Non-Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 55.4,
    "Overall Survival (Months)": 55.2,
    "MSK ID": "LSDNR1120"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID143",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 5.1,
    "Overall Survival (Months)": 25,
    "MSK ID": "NR9765"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID144",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "PR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 71.9,
    "Overall Survival (Months)": 72.4,
    "MSK ID": "PR4091"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID145",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "PR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 72.2,
    "Overall Survival (Months)": 72.8,
    "MSK ID": "PR4092"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID146",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "SD",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 11.2,
    "Overall Survival (Months)": 24,
    "MSK ID": "SD1494"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID147",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 2.6,
    "Overall Survival (Months)": 2.7,
    "MSK ID": "NR4083"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID148",
    "Primary Tumor/Cancer Type": "NA",
    "Response": "PR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": "NA",
    "Overall Survival (Months)": "",
    "MSK ID": "PR11217"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID149",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 3.1,
    "Overall Survival (Months)": 12,
    "MSK ID": "NR9341"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID150",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "LS",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 35.3,
    "Overall Survival (Months)": 34.8,
    "MSK ID": "LSD3484"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID151",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "PR",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 25.2,
    "Overall Survival (Months)": 25.3,
    "MSK ID": "PR4046"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID152",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "SD",
    "Response Group": "Non-responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 2.9,
    "Overall Survival (Months)": 8.4,
    "MSK ID": "SD6494"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID153",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Non-Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 10.3,
    "Overall Survival (Months)": 48,
    "MSK ID": "CR7623"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID154",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Responders",
    "Cohort Group": "Discovery",
    "Response Duration (months)": 13,
    "Overall Survival (Months)": 64.8,
    "MSK ID": "CR4880"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID155",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "CR",
    "Response Group": "Non-Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 20.4,
    "Overall Survival (Months)": 20.4,
    "MSK ID": "CRNR2472"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID156",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 1.8,
    "Overall Survival (Months)": 2.5,
    "MSK ID": "NR9445"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID157",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 2.1,
    "Overall Survival (Months)": 14.9,
    "MSK ID": "NR8815"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID158",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 2.3,
    "Overall Survival (Months)": 7.2,
    "MSK ID": "NR9449"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID159",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "LS",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 14.6,
    "Overall Survival (Months)": 40.1,
    "MSK ID": "LSD2057"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID160",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 2.6,
    "Overall Survival (Months)": 9.8,
    "MSK ID": "NR6842"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID161",
    "Primary Tumor/Cancer Type": "Acral Melanoma",
    "Response": "LS",
    "Response Group": "Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 15.3,
    "Overall Survival (Months)": 40.8,
    "MSK ID": "LSD6819"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID162",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 2.4,
    "Overall Survival (Months)": 15,
    "MSK ID": "NR6689"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID163",
    "Primary Tumor/Cancer Type": "Cutaneous Melanoma",
    "Response": "NR",
    "Response Group": "Non-responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 1.8,
    "Overall Survival (Months)": 9.8,
    "MSK ID": "NR2137"
  },
  {
    "Study ID": "PICI-MS-101",
    "Subject ID": "PID164",
    "Primary Tumor/Cancer Type": "Uveal Melanoma",
    "Response": "LS",
    "Response Group": "Non-Responders",
    "Cohort Group": "Validation",
    "Response Duration (months)": 16.7,
    "Overall Survival (Months)": 32.4,
    "MSK ID": "LSDNR1650"
  }
]
